IMTX News and Press, Immatics N.V.

News Releases

IMTX News Releases

June 16, 2026 02:19:43 am

IMTX : NASDAQ

SeekingAlpha

Immatics: PRAME Is Becoming More Than A Single-Asset Story

June 01, 2026 08:00:00 am

IMTX : NASDAQ

GlobeNewswire

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

May 31, 2026 09:00:00 am

IMTX : NASDAQ

GlobeNewswire

Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer

May 30, 2026 08:00:00 am

IMTX : NASDAQ

GlobeNewswire

Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting

May 12, 2026 07:11:47 am

IMTX : NASDAQ

SeekingAlpha

Immatics GAAP EPS of -Euro0.43, revenue of Euro7.61M

May 12, 2026 07:00:00 am

IMTX : NASDAQ

GlobeNewswire

Immatics Announces First Quarter 2026 Financial Results and Business Update

April 21, 2026 10:25:55 am

IMTX : NASDAQ

GlobeNewswire

Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting

April 17, 2026 03:00:00 pm

IMTX : NASDAQ

GlobeNewswire

PRAME-directed Cell Therapy Using Immatics' TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma

March 09, 2026 01:35:15 pm

IMTX : NASDAQ

SeekingAlpha

Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot

March 05, 2026 04:58:56 pm

IMTX : NASDAQ

SeekingAlpha

Immatics GAAP EPS of -Euro1.61, revenue of Euro48.2M

	Next 10

Immatics N.V. (NASDAQ : IMTX ) News

News Releases

Subscribe to Our Newsletter

Download The Market Wire News App

Schedule a 30 minute Brand Awareness meeting with Market Wire News

Link Market Wire News to Your X Account